In addition to Sipucleucel-T vaccine, other peptide-based cancer vaccines are developed for prostate cancer, such as Cancer-associated membrane carbohydrates, including ganglioside (GM2), mucin 1 (MUC1), globo H and Thompson–Friedenreich antigen. The gene discussed is MUC1; the disease is cancer.